AEMPS begins therapeutic positioning reports for products backed by October CHMP opinions
Spain's medicines agency has started work on IPTs for new medicines and extensions with positive October CHMP opinions, including Foundayo, Rasonque and Yuviwel.
The Spanish Agency for Medicines and Medical Devices (AEMPS) has begun preparing therapeutic positioning reports (IPTs) for medicines that received a positive centralised-procedure opinion at the October 2026 meeting of the EMA's CHMP. The notice, published on 16 November under reference IPT 10/2026, covers new medicines as well as new indications and modifications to existing ones.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
Already a subscriber? Enter your email below: we'll send you a sign-in link. No password needed.
Article written by VigiEye from the official source (AEMPS). AI-assisted; check the source before acting.